The tumor development of PyMT tumors is well-characterized, with tumor cells decreasing ER/PR expression and increasing HER2 levels when the tumor develops into mammary intraepithelial neoplasia (MIN) and late carcinoma (Lin et al., 2003[35]). Here, ESR1 is linked to neoplasm.